EP2678072A1 - Implantable neurostimulator with a circuit board and a connector - Google Patents
Implantable neurostimulator with a circuit board and a connectorInfo
- Publication number
- EP2678072A1 EP2678072A1 EP12707023.3A EP12707023A EP2678072A1 EP 2678072 A1 EP2678072 A1 EP 2678072A1 EP 12707023 A EP12707023 A EP 12707023A EP 2678072 A1 EP2678072 A1 EP 2678072A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- connector assembly
- neurostimulator
- connector
- pins
- stimulation system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000638 stimulation Effects 0.000 claims abstract description 82
- 230000000712 assembly Effects 0.000 claims abstract description 44
- 238000000429 assembly Methods 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims description 25
- 230000008878 coupling Effects 0.000 claims description 20
- 238000010168 coupling process Methods 0.000 claims description 20
- 238000005859 coupling reaction Methods 0.000 claims description 20
- 229920001296 polysiloxane Polymers 0.000 claims description 14
- 125000006850 spacer group Chemical group 0.000 claims description 14
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 238000005476 soldering Methods 0.000 claims description 9
- 239000004593 Epoxy Substances 0.000 claims description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- PXAGFNRKXSYIHU-UHFFFAOYSA-N 1,3-dichloro-2-(2,6-dichlorophenyl)benzene Chemical compound ClC1=CC=CC(Cl)=C1C1=C(Cl)C=CC=C1Cl PXAGFNRKXSYIHU-UHFFFAOYSA-N 0.000 description 18
- 239000000758 substrate Substances 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 12
- 239000000919 ceramic Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000000278 spinal cord Anatomy 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 235000008113 selfheal Nutrition 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000019430 Motor disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3752—Details of casing-lead connections
- A61N1/3754—Feedthroughs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36125—Details of circuitry or electric components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3752—Details of casing-lead connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
Definitions
- the present invention relates to implantable medical devices, and more particularly, to devices and methods for providing stimulation therapy to patients.
- Implantable stimulation devices generate and deliver electrical stimuli to bodily nerves and tissues for the therapy of various biological disorders, such as: pacemakers to treat cardiac arrhythmia; defibrillators to treat cardiac fibrillation; cochlear stimulators to treat deafness; retinal stimulators to treat blindness; muscle stimulators to produce coordinated limb movement; spinal cord stimulators to treat chronic pain; cortical and deep brain stimulators to treat motor and psychological disorders; and other neural stimulators to treat urinary incontinence, sleep apnea, shoulder sublaxation, etc.
- the present invention may find applicability in all such applications, although the description that follows will generally focus on the use of the invention within a spinal cord stimulation system, such as that disclosed in U.S. Patent 6,516,227, issued February 4, 2003 in the name of inventors Paul Meadows et al., which is incorporated herein by reference in its entirety.
- Typical implantable stimulation devices include a neurostimulator, one or more leads electrically coupled to the neurostimulator, and an array of stimulator electrodes on each lead.
- the stimulator electrodes are in contact with or near the bodily tissue to be stimulated.
- a pulse generator in the neurostimulator generates electrical pulses that are delivered by the electrodes to bodily tissue.
- the neurostimulator typically includes an implantable rounded case having circuitry such as a printed circuit board, a telemetry coil for communicating with an external programmer to control the electrical pulses, and a charging coil for charging the neurostimulator.
- the neurostimulator also includes a header having one or more connector assemblies for receiving the leads, wherein the connector assemblies have one or more connector contacts for coupling to the leads.
- the header In common models of such neurostimulators, there are two connector assemblies in the header, each having eight contacts.
- Another disadvantage of having the telemetry coil in the header is that the coil and the feedthroughs connected to the coil take up space in the header, which may be limited based on the complexity of the stimulation system. At the same time, it is desirable to make stimulation devices smaller for patient comfort. Moreover, while previous neurostimulators had eight or sixteen contacts for coupling to the electrode leads, newer designs may include thirty-two or more contacts, further limiting space in the header.
- a tissue stimulation system has at least one implantable
- the neurostimulator includes at least one connector assembly configured for respectively receiving the at least one neurostimulation lead, a case, a circuit board positioned in the case, a telemetry coil positioned in the case that is electrically coupled to the circuit board and spaced a distance away from the circuit board, and a charging coil positioned in the case that is electrically coupled to the circuit board.
- the telemetry coil is positioned on a spacer that spaces the telemetry coil the distance away from the circuit board.
- a plurality of pins are affixed to the spacer, wherein at least one of the pins electrically couples the telemetry coil to the circuit board, and at least one of the pins mechanically couples the telemetry coil to the circuit board.
- an implantable neurostimulator has a case, a circuit board positioned in the case, a telemetry coil positioned in the case that is electrically coupled to the circuit board and spaced a distance away from the circuit board, and a charging coil positioned in the case that is electrically coupled to the circuit board.
- the telemetry coil is positioned on a spacer that spaces the telemetry coil the distance away from the circuit board.
- a plurality of pins are affixed to the spacer, wherein at least one of the pins electrically couples the telemetry coil to the circuit board, and at least one of the pins mechanically couples the telemetry coil to the circuit board.
- a tissue stimulation system in a third aspect of the present invention, includes at least one implantable neurostimulation lead and an implantable neurostimulator.
- the neurostimulator has a header with at least one connector assembly configured for respectively receiving the at least one
- the system includes a feedthrough assembly with a plurality of pins coupled to the flex circuit that electrically couple the flex circuit to the at least one connector assembly.
- one or more of the plurality of pins traverse through one or more holes in the flex circuit.
- the feedthrough assembly has a metal flange forming a well containing an insulative material, and the pins extend from the flex circuit through the insulative material.
- the at least one connector assembly has a plurality of connector contacts for electrically coupling with the neurostimulation lead, and the pins are electrically coupled to the connector contacts.
- an implantable neurostimulator has at least one connector assembly configured for receiving at least one neurostimulation lead, a circuit board having programming circuitry, and a flex circuit coupled between the at least one connector assembly and the circuit board.
- the system includes a feedthrough assembly with a plurality of pins coupled to the flex circuit that electrically couple the flex circuit to the at least one connector assembly.
- one or more of the plurality of pins traverse through one or more holes in the flex circuit.
- the feedthrough assembly has a metal flange forming a well containing an insulative material, and the pins extend from the flex circuit through the insulative material.
- the at least one connector assembly has a plurality of connector contacts for electrically coupling with the neurostimulation lead, and the pins are electrically coupled to the connector contacts.
- a tissue stimulation system in a fifth aspect of the present invention, includes at least one implantable neurostimulation lead and an implantable neurostimulator.
- the neurostimulator has at least one connector assembly configured for respectively receiving the at least one neurostimulation lead, a fastener configured for securing the respective one of the at least one neurostimulation leads in the at least one connector assembly, and at least one septum, each having an outer block and an inner block framed within the outer block. Adjacent edges of the inner and outer blocks form at least one slot for receiving a tool for manipulating the fastener for securing the respective one of the at least one neurostimulation leads in the respective one of the at least one connector assembly.
- the neurostimulator has a retainer in which the at least one connector assembly is positioned.
- a connector block is coupled to each at least one connector assembly and has the fastener positioned therein.
- the outer and inner blocks of the at least one septum are composed of silicone.
- the neurostimulator has a shell housing the at least one connector assembly, and the shell has a first transverse line and a second transverse line both aligned parallel to the at least one connector assembly.
- the first transverse line extends between first opposing ends of the shell
- the second transverse line extends between second opposing ends of the shell
- the first transverse line is shorter than the second transverse line.
- at least one upper connector assembly longitudinally aligned along the first transverse line
- at least one lower connector assembly longitudinally aligned along the second transverse line.
- the neurostimulator has at least one upper strain relief member longitudinally aligned along the first transverse line and extending between an end of the at least one upper connector assembly and one of the first opposing ends of the shell, and at least one lower strain relief member longitudinally aligned along the second transverse line and extending between an end of the at least one lower connector assembly and one of the second opposing ends of the shell.
- the at least one upper strain relief member has a shorter length than the at least one lower strain relief member.
- an implantable neurostimulator has at least one connector assembly configured for receiving a neurostimulation lead, a fastener configured for securing the respective one of the at least one neurostimulation leads in the at least one connector assembly, and at least one septum, each having an outer block and an inner block framed within the outer block. Adjacent edges of the inner and outer blocks form at least one slot for receiving a tool for manipulating the fastener for securing the respective one of the at least one neurostimulation leads in the respective one of the at least one connector assembly.
- the neurostimulator has a retainer in which the at least one connector assembly is positioned.
- a connector block is coupled to each at least one connector assembly and has the fastener positioned therein.
- the outer and inner blocks of the at least one septum are composed of silicone.
- the neurostimulator has a shell housing the at least one connector assembly, and the shell has a first transverse line and a second transverse line both aligned parallel to the at least one connector assembly.
- the first transverse line extends between first opposing ends of the shell
- the second transverse line extends between second opposing ends of the shell
- the first transverse line is shorter than the second transverse line.
- at least one upper connector assembly longitudinally aligned along the first transverse line
- at least one lower connector assembly longitudinally aligned along the second transverse line.
- the neurostimulator has at least one upper strain relief member longitudinally aligned along the first transverse line and extending between an end of the at least one upper connector assembly and one of the first opposing ends of the shell, and at least one lower strain relief member longitudinally aligned along the second transverse line and extending between an end of the at least one lower connector assembly and one of the second opposing ends of the shell.
- the at least one upper strain relief member has a shorter length than the at least one lower strain relief member.
- an implantable neurostimulator has a connector header configured for receiving a neurostimulation lead, a divot formed in each of the opposing sides of the connector header, and a suture hole extending between the divots.
- each divot has a plurality of side surfaces, and each side surface is angled less than 90 degrees from an outer surface of the connector header.
- each divot has a bottom surface, and a terminating end of the suture hole is positioned at the bottom surface.
- an implantable neurostimulator has a shell having a first transverse line extending between first opposing ends of the shell, and a second transverse line extending between second opposing ends of the shell, wherein the first transverse line is shorter than the second transverse line.
- the neurostimulator also has at least one upper connector assembly and at least one lower connector assembly housed in the shell, each configured for receiving a neurostimulator lead, wherein the at least one upper connector assembly is longitudinally aligned along the first transverse line, and the at least one lower connector assembly is longitudinally aligned along the second transverse line.
- the neurostimulator also has at least one upper strain relief member longitudinally aligned along the first transverse line and extending between an end of the at least one upper connector assembly and one of the first opposing ends of the shell, and at least one lower strain relief member longitudinally aligned along the second transverse line and extending between an end of the at least one lower connector assembly and one of the second opposing ends of the shell.
- the at least one upper strain relief member has a shorter length than the at least one lower strain relief member.
- the at least one upper connector assembly and at least one lower connector assembly has contacts for electrically coupling to the respective electrode lead received therein.
- the at least one upper connector assembly and at least one lower connector assembly are positioned in a retainer.
- the neurostimulator has at least one upper connector block adjacent the at least one upper connector assembly and at least one lower connector block adjacent the at least one lower connector assembly.
- each of the at least one upper connector block and at least one lower connector block has a fastener disposed therein for securing the respective electrode received in the at least one upper connector assembly and the at least one lower connector assembly.
- FIG. 1 is plan view of one embodiment of a neurostimulation system arranged in accordance with the present inventions
- FIG. 2 is a plan view of the neurostimulation system of Fig. 1 in use with a patient;
- FIG. 3 is a side view of a neurostimulator and electrode leads used in the neurostimulation system of Fig. 1 ;
- FIG. 4 is a perspective view of the neurostimulator of Fig. 3;
- FIGs. 5 and 6 are cut-away views of opposing sides of the neurostimulator of Fig. 3;
- Fig. 7 is a side view of a spacer and telemetry coil from the neurostimulator of Fig. 3;
- Fig. 8 is a cross-section view of the spacer and telemetry coil of Fig. 7;
- FIGs. 9 and 10 are partial exploded view of connector assemblies in a retainer element from the neurostimulator of Fig. 3;
- FIG. 10A is a perspective view of a septum featured in Fig. 9;
- Fig. 10B is an exploded view of the septum of Fig. 10A;
- Fig. 10C is a cross-sectional view of the septum of Fig. 10A taken along the line 10C and connector blocks featured in Fig. 9;
- Fig. 11 is a perspective view of feedthrough pins coupled to the connector assemblies from Fig. 9;
- Fig. 12 is a perspective view of a feedthrough assembly with the feedthrough pins from Fig. 11 ;
- Fig. 13A is a perspective view of a flex circuit having holes for receiving the feedthrough pins from Figs. 1 1 and 12;
- Fig. 13B is a cross-sectional view of the flex circuit in Fig. 13A taken along the line 13B.
- the description that follows relates to a spinal cord stimulation (SCS) system.
- SCS spinal cord stimulation
- the invention lends itself well to applications in SCS, the invention, in its broadest aspects, may not be so limited. Rather, the invention may be used with any type of implantable electrical circuitry used to stimulate tissue.
- the present invention may be used as part of a pacemaker, a defibrillator, a cochlear stimulator, a retinal stimulator, a stimulator configured to produce coordinated limb movement, a cortical stimulator, a deep brain stimulator, peripheral nerve stimulator, microstimulator, or in any other neural stimulator configured to treat urinary incontinence, sleep apnea, shoulder
- an exemplary SCS system 10 generally includes one or more (in this case, two) implantable neurostimulation leads 12, a neurostimulator (i.e., an implantable pulse generator) (IPG) 14, an external remote controller RC 16, a clinician's programmer (CP) 18, an External Trial Stimulator (ETS) 20, and an external charger 22.
- a neurostimulator i.e., an implantable pulse generator
- RC external remote controller
- CP clinician's programmer
- ETS External Trial Stimulator
- the IPG 14 is physically connected via one or more percutaneous lead extensions 24 to the neurostimulation leads 12, which carry a plurality of electrodes 26 arranged in an array.
- the neurostimulation leads 12 are percutaneous leads, and to this end, the electrodes 26 are arranged in-line along the neurostimulation leads 12.
- the electrodes 26 may be arranged in a two-dimensional pattern on a single paddle lead.
- the IPG 14 includes pulse generation circuitry that delivers electrical stimulation energy in the form of a pulsed electrical waveform (i.e., a temporal series of electrical pulses) to the electrode array 26 in accordance with a set of stimulation parameters.
- the ETS 20 may also be physically connected via the percutaneous lead extensions 24 and external cable 30 to the neurostimulation leads 12.
- the major difference between the ETS 20 and the IPG 14 is that the ETS 20 is a non- implantable device that is used on a trial basis after the neurostimulation leads 12 have been implanted and prior to implantation of the IPG 14, to test the
- the RC 16 may be used to telemetrically control the ETS 20 via a bidirectional inductive link 32. Once the IPG 14 and neurostimulation leads 12 are implanted, the RC 16 may also be used to telemetrically control the IPG 14 via a bi- directional magnetic coupling link 34. Such control allows the IPG 14 to be turned on or off and to be programmed with different stimulation parameter sets. The IPG 14 may also be operated to modify the programmed stimulation parameters to actively control the characteristics of the electrical stimulation energy output by the IPG 14. It should be noted that rather than an IPG, the system 10 may alternatively utilize an implantable receiver-stimulator (not shown) connected to the lead 12.
- the power source e.g., a battery
- the power source for powering the implanted receiver, as well as control circuitry to command the receiver-stimulator, will be contained in an external controller/charger inductively coupled to the receiver-stimulator via an
- the CP 18 provides clinician detailed stimulation parameters for
- the CP 18 may perform this function by indirectly communicating with the IPG 14 or ETS 20, through the RC 16, via an IR communications link 36.
- the CP 18 may directly communicate with the IPG 14 or ETS 20 via an RF communications link or magnetic coupling link (not shown).
- the clinician detailed stimulation parameters provided by the CP 18 are also used to program the RC 16, so that the stimulation parameters can be subsequently modified by operation of the RC 16 in a stand-alone mode (i.e., without the assistance of the CP 18).
- the external charger 22 is a portable device used to transcutaneously charge the IPG 14 via an inductive link 38. Once the IPG 14 has been programmed, and its power source has been charged by the external charger 22 or otherwise
- the IPG 14 may function as programmed without the RC 16 or CP 18 being present.
- the electrode leads 12 are implanted within the spinal column 42 of a patient 40.
- the preferred placement of the neurostimulation leads 12 is adjacent, i.e., resting near, or upon the dura, adjacent to the spinal cord area to be stimulated.
- the IPG 14 is generally implanted in a surgically-made pocket either in the abdomen or above the buttocks.
- the IPG 14 may, of course, also be implanted in other locations of the patient's body.
- the lead extension 24 facilitates locating the IPG 14 away from the exit point of the electrode leads 12.
- the CP 18 communicates with the IPG 14 via the RC 16.
- neurostimulation leads 12 and the IPG 14 there are four stimulation leads 12(1 )-12(4), wherein neurostimulation lead 12(1 ) has eight electrodes 26 (labeled E1 -E8), neurostimulation lead 12(2) has eight electrodes 26 (labeled E9-E16), neurostimulation lead 12(3) has eight electrodes 26 (labeled E17- E24), and neurostimulation lead 12(4) has eight electrodes 26 (labeled E24-E32).
- the actual number and shape of leads and electrodes will, of course, vary according to the intended application.
- the IPG 14 comprises an outer case 44 for housing the electronic and other components (described in further detail below), and a header portion 46 coupled to the case 44 for receiving the proximal ends of the neurostimulation leads 12(1 )-12(4) for mating in a manner that electrically couples the electrodes 26 to the electronics within the case 44.
- the outer case 44 is composed of an electrically conductive, biocompatible material, such as titanium 6-4, and forms a hermetically sealed compartment wherein the internal electronics are protected from the body tissue and fluids.
- the case 44 has a rounded configuration with a maximum circular diameter D of about 50 mm, and preferably about 45 mm, and a maximum thickness W of about 10 mm, and preferably about 8 mm.
- the case 44 is formed using any suitable process, such as casting, molding, and the like.
- the header 46 has a rounded configuration that corresponds with that of the case 44, such that the case 44 and the header 46 together form a rounded body.
- the IPG 14 includes pulse generation circuitry 48 (see Fig. 6) that provides electrical stimulation energy in the form of a pulsed electrical waveform to the electrode array 26 in accordance with a set of stimulation parameters programmed into the IPG 14.
- stimulation parameters may comprise electrode combinations, which define the electrodes that are activated as anodes (positive), cathodes (negative), and turned off (zero), percentage of stimulation energy assigned to each electrode (fractionalized electrode configurations), and electrical pulse parameters, which define the pulse amplitude (measured in milliamps or volts depending on whether the IPG 14 supplies constant current or constant voltage to the electrode array 26), pulse width
- pulse rate measured in pulses per second
- burst rate measured as the stimulation on duration X and stimulation off duration Y
- Electrodes will occur between two (or more) activated electrodes, one of which may be the IPG case 44.
- Stimulation energy may be transmitted to the tissue in a monopolar or multipolar (e.g., bipolar, tripolar, etc.) fashion.
- Monopolar stimulation occurs when a selected one of the lead electrodes 26 is activated along with the case 44 of the IPG 14, so that stimulation energy is transmitted between the selected electrode 26 and case 44.
- Bipolar stimulation occurs when two of the lead electrodes 26 are activated as anode and cathode, so that stimulation energy is transmitted between the selected electrodes 26.
- an electrode on one lead 12 may be activated as an anode at the same time that an electrode on the same lead or another lead 12 is activated as a cathode.
- Tripolar stimulation occurs when three of the lead electrodes 26 are activated, two as anodes and the remaining one as a cathode, or two as cathodes and the remaining one as an anode.
- two electrodes on one lead 12 may be activated as anodes at the same time that an electrode on another lead 12 is activated as a cathode.
- the stimulation energy may be delivered between electrodes as monophasic electrical energy or multiphasic electrical energy.
- Monophasic electrical energy includes a series of pulses that are either all positive (anodic) or all negative
- Multiphasic electrical energy includes a series of pulses that alternate between positive and negative.
- multiphasic electrical energy may include a series of biphasic pulses, with each biphasic pulse including a cathodic (negative) stimulation pulse and an anodic (positive) recharge pulse that is generated after the stimulation pulse to prevent direct current charge transfer through the tissue, thereby avoiding electrode degradation and cell trauma. That is, charge is conveyed through the electrode-tissue interface via current at an electrode during a stimulation period (the length of the stimulation pulse), and then pulled back off the electrode-tissue interface via an oppositely polarized current at the same electrode during a recharge period (the length of the recharge pulse).
- the IPG 14 comprises multiple electronic components, including an electronic substrate assembly 50 and a battery 52 contained within the case 44, and a flex circuit 140 (see Figs. 13A and 13B) coupled to the electronic substrate assembly 50.
- the flex circuit 140 serves to couple the electronic substrate assembly 50 to the electronic components in the header 46, which will be discussed in further detail below.
- the electronic substrate assembly 50 includes a printed circuit board (PCB) 54 to which the previously described pulse generation circuitry 48 is mounted in the form of microprocessors, integrated circuits, capacitors, and other electronic components.
- PCB printed circuit board
- the electronic substrate assembly 50 further comprises a telemetry coil 56, a charging coil 58, and telemetry/charging circuitry 60 mounted to the PCB 54. While a portion of the electronic components of the IPG 14 will be described in further detail below, additional details of the IPG 14 and electrical components are disclosed in U.S. Patent No. 6,516,227, which was previously incorporated herein.
- the telemetry coil 56 and charging coil 58 are positioned on opposing sides of the PCB 54.
- the electronic substrate assembly 50 further comprises a spacer 62 on which the telemetry coil 56 is positioned to space the telemetry coil 56 a distance Dt away from the PCB 54.
- the spacer 62 is a bobbin 62.
- the bobbin 62 has a main body 64 and an outer flange 66 extending around the periphery of the main body 64 on which the telemetry coil 56 sits, such that the coil 56 is wound around the main body 64 in a shape corresponding to that of the main body 64.
- the telemetry coil 56 and the main body 64 of the bobbin 62 have a D-shaped configuration for encompassing a wide area in the case 44 to improve coupling, and hence the reliability of data transfer, between the telemetry coil 56 and the RC 16.
- the bobbin 62 is beneficial for manufacture, as the bobbin 62 provides a base on which to shape the telemetry coil 56, creating a more consistent design than freeform winding of the telemetry coil 56.
- a number of pins 68, 70 are affixed to the bobbin for coupling the telemetry coil 56 to the PCB 54.
- the bobbin 62 has three holes 72 extending through the main body 64 of the bobbin 62 for receiving three pins 68, 70.
- two of the pins 68 electrically connect the telemetry coil 56 to the PCB 54, and in particular, one pin 68 connects the ground port of the telemetry coil 56, and the other pin connects the signal port of the telemetry coil 56.
- the third pin 70 mechanically connects the telemetry coil 56 to the PCB 54.
- the two holes 72 for receiving the two electrical pins 68 are located on one side of the main body 64 of the bobbin 62, and the one hole 72 for receiving the mechanical pin 70 is located on an opposing side of the main body 64 of the bobbin 62.
- the pins 68, 70 may be secured in the holes 72 by welding or other suitable means. In this manner, the pins 68, 70 facilitate secure, accurate placement of the telemetry coil 56 relative to the PCB 54, while the two pins 68 also provide an electrical connection between the telemetry coil 56 and the PCB 54. In other embodiments, only one pin may be used to electrically connect the telemetry coil 56 to the PCB 54, or more pins may be used to electrically and/or mechanically connect the telemetry coil 56 to the PCB 54.
- many typical IPGs contain a charging coil in the case and a telemetry coil in the header.
- positioning both the charging coil 58 and the telemetry coil 56 in the case 44 allows more room in the header 46 for other electronic components.
- positioning the telemetry coil 56 in the case 44 eliminates the need for a feedthrough that connects the electronic substrate assembly 50 with the telemetry coil 56, as opposed to when a telemetry coil is in the header.
- wireless data telemetry between the RC 16 and the IPG 14 occurs via inductive coupling, for example, magnetic inductive coupling. This coupling occurs between the telemetry coil 56 in the IPG 14 and a
- the charging coil 58 when power is to be transmitted from the external charger 22 to the IPG 14, the charging coil 58 is energized with an alternating current (AC). Such energizing is generally of a constant frequency and may be of a larger magnitude than that used during data transfer with the telemetry coil 56, but the basic operation is similar.
- the IPG 14 can also communicate back to the external charger 22 by modulating the impedance of the charging coil 58. This change in impedance is reflected back to the external charger 22, which
- LSK Load Shift Keying
- One possible issue that may arise with positioning both the telemetry coil 56 and the charging coil 58 in the case 44 is that the mutual inductance of the coils 56, 58 may interfere with each other if both coils 56, 58 are receiving and transmitting data at the same time.
- One method of addressing this is to include decoupling circuitry (not shown) for decoupling the charging coil 58 from the charging circuitry 60 during periods of telemetry between the IPG 14 and the RC 16.
- the decoupling circuitry may be activated based on one or more operating factors, for example, when the telemetry coil 56 is sending or receiving data to/from the RC 16, or when the charging circuitry 60 detects no charging alternating current for the charging coil 58 to receive.
- the LSK data signal is used to transmit serial data to the external charger 22 during charging, as is typical, and is also used as a control signal to reduce loading of the telemetry coil 56 during data telemetry between the IPG 14 and the RC 16.
- Using the preexisting LSK circuitry in this method requires no change in telemetry circuitry other than to program the IPG 14 circuitry to assert LSK data during periods of data telemetry.
- the enhanced circuitry improves reliability of telemetry between the RC 16 and the telemetry coil 56 without substantial circuitry changes. Additional information regarding the enhanced circuitry is detailed in Application No. 12/616,178, filed November 1 1 , 2009, which is incorporated herein by reference.
- the bobbin 62 also provides operational benefits with positioning the telemetry coil 56 and the charging coil 58 in the case 44. For example, the bobbin 62 lessens the interference between the coils 56, 58 by increasing the distance between the telemetry coil 56 and the charging coil 58, as described above.
- the bobbin 62 places the telemetry coil 56 in closer proximity to the case 44 to optimize telemetry using resistance from the case 44.
- the telemetry coil 56 may communicate on a seven-band frequency that is achieved by attaining a loss in transmission from resistance, e.g., resistance from adjacent material.
- the header provides the resistance needed to obtain the ideal frequency.
- the case 44 in positioning the telemetry coil 56 closer to the case 44, the case 44 provides the resistance needed to create the desired seven-band frequency for telemetry coil 56 transmission.
- the flex circuit 140 serves to couple the electronic substrate assembly 50 to the electronic components in the header 46.
- the flex circuit 140 is coupled to the PCB 54 and also to feedthrough pins, described in further detail below, that in turn are coupled to lead extensions 24 received in the header 46.
- the flex circuit 140 is a flexible metallic component (see e.g., Figs. 13A and 13B)
- the flex circuit 140 serves as an interface between the electronic substrate assembly 50 and the electronic components in the header 46 to provide an electrical coupling function along with the ability to be bent in a suitable configuration to accommodate the size and structure of the IPG 14.
- the flex circuit 140 may be permanently coupled to the PCB 54, for example, by soldering, laser-welding, applying conductive epoxy or similar adhesive, or crimping.
- the flex circuit 140 may be detachably coupled to the PCB 54, for example, by edge connectors such as zero insertion force connectors, snap-fit mechanisms, friction-fit mechanisms, and fasteners such as screws.
- the substrate of the flex circuit 140 is composed primarily of polyamide, which may be the same material from which the PCB 54 is primarily composed. Other materials may also be used for the substrate of the flex circuit 140.
- the electronic components within the case 44 are electrically coupled to the electrodes 26 via lead extensions 24 received in the header 46, as shown in Fig. 4.
- the header 46 includes: a shell 76 coupled to the case 44; a plurality of ports 78; a retainer 80; one or more connector assemblies 82 positioned in the retainer 80; a corresponding number of connector blocks 84 positioned in the retainer 80; one or more septums 86; and a plurality of strain relief members 88.
- the shell 76 is formed using any suitable process, such as casting, molding, and the like, and is composed of a rigid material that does not interfere with the electrical functions of the IPG 14, such as thermoset.
- the plurality of ports 78 extend through the shell 76 and are configured for receiving the lead extensions 24.
- the number of ports 78 corresponds to the number of lead extensions 24.
- the header ports 78 are also aligned with retainer ports 90, such that the lead extensions 24 are received in the header ports 78 and then in the retainer 80 through the retainer ports 90.
- the retainer ports 90 (in this illustrated
- four ports are in turn aligned with the connector assemblies 82, such that the lead extensions 24 are received through the retainer ports 90 and then within the connector assemblies 82.
- the retainer 80 receives the connector assemblies 82 in corresponding retainer channels 92 that hold each respective connector assembly 82 in position.
- the retainer 80 is preferably composed of a rigid material, e.g., thermoplastic, such that the connector assemblies 82 can be affixed relative to each other.
- the connector assemblies 82 are releasably disposed in the retainer 80 in a suitable manner, such as with an interference fit, snap connection, binders, or other suitable mechanisms. Partitions 94 in the retainer 80 keep the connector assemblies 82 separated to minimize interference.
- the connector assemblies 82 receive and make electrical contact with the lead extensions 24.
- Each connector assembly 82 has a housing 96, a hollow center region 98 extending between a proximal end 100 and a distal end 102 of the housing 96, a plurality of openings 104 transversely formed through the wall of the housing 96, and a plurality of connector contacts 106 located within the hollow center region 98.
- Suitable materials for the housing 96 include, for example, silicone and polyurethane, and multiple materials may be included.
- Each lead extension 24 is received through the distal end 102 of the respective housing 96 into the respective hollow center region 98.
- the openings 104 in the housing 96 extend from an outer surface of the housing 96 to the hollow center region 98.
- the housing openings 104 are linearly aligned along a side surface of the housing 96.
- Each opening 104 provides access to a corresponding connector contact 106 within the housing 96.
- the connector contacts 106 are electrically coupled to the electronic substrate assembly 50 in the case 44 by a plurality of feedthrough pins, which are explained below in greater detail.
- the connector contacts 106 electrically couple with terminals 108 disposed on the lead extensions 24.
- the terminals 108 are in turn coupled to the lead electrodes 26 with conductive wires (not shown).
- the number and spacing of the connector contacts 106 in each connector assembly 82 correspond to the number and spacing of the terminals 108 on each lead extension 24 to optimize coupling.
- each of the four connector assemblies 82 has eight contacts 106, and each of the four lead extensions 24 has eight terminals 108.
- each connector contact 106 electrically couples to a corresponding terminal 108 on the lead extension 24. This results in coupling between the electronic substrate assembly 50, which is coupled to the connector contacts 106 by the flex circuit 140 and the feedthrough pins, and the electrodes 26, which are coupled to the terminals 108.
- the retainer 80 has a number of end stops 1 10 each located at the proximal ends 100 of the housings 96 of the connector assemblies 82.
- the end stops 1 10 are typically formed of a compressible material, such as silicone, and may be shaped as a block or alternatively have a curved bowl-shaped configuration.
- the end stops 1 10 help to set the pitch for placement of the connector contacts 106 during manufacture, for example, during precision-based processes such as laser soldering, to prevent irregular placement of the connector assemblies 82 that would lead to increased expense and quality issues.
- the end stops 1 10 help limit movement of the connector assemblies 82 to optimize transmission of electrical pulses from the connector assemblies 82 to the lead electrodes 26.
- the connector blocks 84 are located at the distal end 102 of the housing 96 and may also be coupled to the housing 96 and/or a wall of the retainer 96.
- Each connector block 84 defines a port 1 12 aligned with the hollow center region 98 for receiving a lead extension 24.
- Each connector block 84 also has an aperture 1 14 on a side of the connector block 84 through which a fastener 1 16, such as a setscrew or pin, is inserted and secured against the lead extension 24 received therein.
- the septums 86 have one or more slots 1 18 aligned with the connector block apertures 1 14 for receiving a fastening tool to secure the fastener 1 16 in each aperture 1 14.
- the septums 86 are positioned adjacent to, and may also be coupled to, the connector blocks 84. In the illustrated embodiment, two septums 86 are positioned on opposing sides of the header 46, wherein each septum 86 is adjacent to two connector blocks 84.
- Each septum 86 has an outer block 120 and an inner block 122, as shown in Fig.
- the blocks 120, 122 are composed of a compressible material, such as silicone.
- the demarcation between the blocks 120, 122 forms the slots 1 18 for receiving the fastening tool.
- the upper edge of the inner block 122 forms an upper slot 1 18 with the outer block 120
- the lower edge of the inner block 122 forms a lower slot 1 18 with the outer block 120.
- the upper slot 1 18 in each septum 86 is adjacent to the aperture 1 14 in each upper connector block 84
- the lower slot 1 18 in each septum 86 is adjacent to the aperture 1 14 in the lower connector block 84.
- the block is typically pierced with a knife to create the slot for receiving the fastening tool.
- a knife to create the slot for receiving the fastening tool.
- silicone can demonstrate a tendency to "self-heal,” such that a slot formed by piercing a silicone block could close at least partially over time.
- the tendency to self-heal is mitigated, and the slot remains intact.
- Each septum 86 is positioned in an opening 124 formed through a surface of the header 46 (see Fig. 4), wherein edges of the opening 124 extend over the space underneath to form a frame 126, and the septum 86 is positioned under the frame 126.
- the septum is pushed from outside the header into an opening in the header. However, this often results in the septum becoming loose and being expelled from the header.
- the septum 86 is pushed into the opening 124 from inside the header 46, such that the frame 126 edges extending over the opening 124 prevent the septum 86 from moving outside the opening 124.
- An adhesive such as epoxy, is also applied to adhere the septum 86 to the header 46, such that both mechanical and adhesive elements hold the septum 86 in place. Additional details regarding the connector assemblies and the components associated therewith are found in U.S. Provisional Patent Application No. 61/378,613, filed August 31 , 2010, U.S. Patent No. 7,244,150, and U.S. Patent Application Serial No. 1 1 /532,844, which are incorporated herein by reference.
- the strain relief members 88 in the header 46 extend between each of the retainer ports 90 and the header ports 78.
- the strain relief members 88 are formed as annular seals that help to prevent current leakage outside the header 46 and to hold the lead extensions 24 in position when inserted in the connector assemblies 82 while preventing damage to the lead extensions 24.
- the lower strain relief members 88 have a longer length than the upper strain relief members 88. This is because there is more space between the distal end 102 of the lower connector assembly 82 and retainer port 90 and the corresponding header port 78 than between the upper connector assembly 82 and retainer port 90 and the corresponding header port 78.
- the header 46 also features a suture hole 128 that extends between opposing sides of the header 46.
- a suture needle can go through suture hole 128 by entering one side of the header 46 and exiting on the other side.
- a clinician implanting the IPG 14 may thus use a suture needle with the suture hole 128 to affix the IPG 14 to bodily tissue to help hold the IPG 14 in place.
- Each side of the suture hole 128 is surrounded by a divot 130 in an outer surface of the header 46.
- the divot 130 is cut into the outer surface of the header 46 and has a plurality of side surfaces 132, each side surface 132 preferably angled less than 90 degrees from the outer surface of the header 46, and a bottom surface 134 where the suture hole 128 is positioned.
- the divot 130 and its configuration allow for ease in accessing the header 46 with a suture needle, particularly a curved suture needle, to affix the IPG 14 to bodily tissue.
- a feedthrough assembly 136 electrically couples the electronic substrate assembly 50 with the connector assemblies 82.
- the feedthrough assembly 136 includes a plurality of feedthrough pins 138, a metal flange 142 defining a well 144, and one or more ceramic plates 146 positioned in the well 144.
- the feedthrough pins 138 are formed of 10ml_ wire composed of 90/10 platinum/iridium. In other feedthrough assemblies, the pins are composed of 80/20 platinum/iridium, however, this is less ductile and less compatible with soldering processes during manufacture.
- the number of feedthrough pins 138 corresponds to the number of connector contacts 106 in the connector assemblies 82.
- the feedthrough pins 138 are coupled to the PCB 54 and extend through the case 44 and header 46 to the connector assemblies 82, where the pins 138 are coupled to the connector contacts 106.
- the feedthrough pins 138 may be coupled to the connector contacts 106 by any suitable method including, for example, welding, soldering, and the like.
- the feedthrough pins 138 are sufficiently long to reach the connector contacts 106 without requiring an additional wire to be soldered to each pin 136. This eliminates the need for additional manufacturing steps, thus limiting production costs and quality issues that would otherwise arise.
- the feedthrough pins 138 are each coupled to the flex circuit 140, which may be achieved in various manners. In the illustrated
- each of the feedthrough pins 138 is inserted in a corresponding hole 148 in the flex circuit 140 (see Fig. 13A).
- the flex circuit 140 is initially flat, wherein each of the feedthrough pins 138 is inserted through the corresponding hole 148.
- gold braze is applied on the underside of each hole 148 around each pin 138 and seeps through the holes 148 to seal the pins 138 in the holes 148. This provides a metallurgical adhesive and electrical connection, which may be advantageous over other sealants that only serve as an adhesive.
- Conductive epoxy may also be used to seal the pins 138 in the holes 148.
- the flex circuit 140 is then bent into a curved configuration to suitably fit in the IPG 14 and to orient the pins 138 upward for insertion through the header 46.
- the feedthrough pins 138 are attached to an edge of the flex circuit 140, for example, by laser-soldering or with a conductive epoxy. In another embodiment, a portion of the pins 138 are attached to an edge of the flex circuit 140, and the remaining pins are inserted through holes 148 in the flex circuit 140.
- the feedthrough pins 138 extend through the metal flange 142, which is located at the base of the header 46.
- the metal flange 142 is composed of a biocompatible material, such as titanium.
- the metal flange 142 defines the well 144, which is occupied by the ceramic plates 146.
- the ceramic plates 146 are fused to the metal flange 142 with gold braze.
- two ceramic plates 146 are positioned adjacent each other in the well 144.
- Alternative embodiments may consist of only one ceramic plate 146 that occupies the well 144.
- the ceramic plates 146 have a number of holes 150 corresponding to the number of feedthrough pins 138, such that each pin 138 extends through one corresponding hole 150.
- the pins 138 are fused to the ceramic plates 146 with gold braze that is applied on the underside of the plates 146 and seeps through the holes 150 to cover the pins 138 along the length of the holes 150.
- the ceramic plates 146 have a lower coefficient of expansion than the titanium of the metal flange 142, such that when the components are heated to extremely high temperatures during manufacture, the ceramic plates 146 expand less than the flange 142. As a result, less of the gold braze can seep from between the metal flange 142 and the ceramic plates 146. Also, since the holes 150 receiving the pins 138 in the plates 146 do not widen significantly, the gold braze securing the pins 138 is substantially prevented from seeping through the holes 150, thus serving to stabilize the pins 138.
- each of the feedthrough pins 138 is covered with a silicone tube 152 from the base of the ceramic plates 146 up to the point at which the feedthrough pins 138 couple to the connector contacts 106 (see Fig. 5). Additionally, the well 144 is filled with silicone (not shown) to provide further isolation between the pins 138.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22168815.3A EP4062968A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
EP23157722.2A EP4218917A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161446438P | 2011-02-24 | 2011-02-24 | |
PCT/US2012/026370 WO2012116214A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP23157722.2A Division EP4218917A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
EP22168815.3A Division EP4062968A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
EP22168815.3A Division-Into EP4062968A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2678072A1 true EP2678072A1 (en) | 2014-01-01 |
EP2678072B1 EP2678072B1 (en) | 2022-06-15 |
Family
ID=45787392
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12707023.3A Active EP2678072B1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
EP22168815.3A Withdrawn EP4062968A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
EP23157722.2A Pending EP4218917A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22168815.3A Withdrawn EP4062968A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
EP23157722.2A Pending EP4218917A1 (en) | 2011-02-24 | 2012-02-23 | Implantable neurostimulator with a circuit board and a connector |
Country Status (6)
Country | Link |
---|---|
US (5) | US8738138B2 (en) |
EP (3) | EP2678072B1 (en) |
JP (1) | JP2014508600A (en) |
AU (1) | AU2012220569B2 (en) |
CA (1) | CA2828234A1 (en) |
WO (1) | WO2012116214A1 (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084901B2 (en) | 2006-04-28 | 2015-07-21 | Medtronic, Inc. | Cranial implant |
EP2644227B1 (en) | 2008-07-30 | 2016-12-28 | Ecole Polytechnique Fédérale de Lausanne | Apparatus for optimized stimulation of a neurological target |
EP2382008B1 (en) | 2008-11-12 | 2015-04-29 | Ecole Polytechnique Federale De Lausanne | Microfabricated neurostimulation device |
JP5927176B2 (en) | 2010-04-01 | 2016-06-01 | エコーレ ポリテクニーク フェデラーレ デ ローザンヌ (イーピーエフエル) | Device for interacting with neural tissue and methods of making and using it |
WO2013111137A2 (en) | 2012-01-26 | 2013-08-01 | Rainbow Medical Ltd. | Wireless neurqstimulatqrs |
US9008778B2 (en) | 2012-08-23 | 2015-04-14 | Boston Scientific Neuromodulation Corporation | Implantable electrical stimulation systems with shielded control module and methods for making and using |
US9861812B2 (en) | 2012-12-06 | 2018-01-09 | Blue Wind Medical Ltd. | Delivery of implantable neurostimulators |
US20150018911A1 (en) | 2013-07-02 | 2015-01-15 | Greatbatch Ltd. | Apparatus, system, and method for minimized energy in peripheral field stimulation |
WO2015034833A1 (en) * | 2013-09-06 | 2015-03-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for reducing electromagnetic field-induced heating from an implantable pulse generator |
CN110585588A (en) | 2014-05-16 | 2019-12-20 | 阿莱瓦神经治疗股份有限公司 | Implantable microelectrode device |
US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
US9782581B2 (en) | 2014-06-27 | 2017-10-10 | Boston Scientific Neuromodulation Corporation | Methods and systems for electrical stimulation including a shielded sheath |
EP3180071B1 (en) | 2014-08-15 | 2021-09-22 | Axonics, Inc. | External pulse generator device and associated system for trial nerve stimulation |
US12053630B2 (en) | 2014-08-17 | 2024-08-06 | Coloplast A/S | Implantable pulse generator with automatic jump-start |
EP3180069B1 (en) | 2014-08-17 | 2020-05-13 | Nine Continents Medical, Inc. | Miniature implatable neurostimulator system for sciatic nerves and their branches |
US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
US9814815B2 (en) | 2014-12-17 | 2017-11-14 | Heartware, Inc. | Implantable connector |
WO2016160423A1 (en) | 2015-03-27 | 2016-10-06 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using electrical stimulation systems to reduce rf-induced tissue heating |
US10238879B2 (en) * | 2015-04-06 | 2019-03-26 | Cardiac Pacemakers, Inc. | Implantable medical devices with flexible interconnect having strain relief |
WO2016176645A1 (en) | 2015-04-30 | 2016-11-03 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems having a rf shield along at least the lead and methods of making and using |
KR101656723B1 (en) * | 2015-06-30 | 2016-09-12 | 재단법인 오송첨단의료산업진흥재단 | Feedthrough making method |
US10105540B2 (en) | 2015-11-09 | 2018-10-23 | Bluewind Medical Ltd. | Optimization of application of current |
US10576292B2 (en) * | 2015-11-29 | 2020-03-03 | Boston Scientific Neuromodulation Corporation | Skull-mounted deep brain stimulator |
US10420950B2 (en) | 2015-11-29 | 2019-09-24 | Boston Scientific Neuromodulation Corporation | Implantable pulse generator usable during a trial stimulation phase and externally powered by magnetic inductive coupling |
WO2017134587A1 (en) | 2016-02-02 | 2017-08-10 | Aleva Neurotherapeutics, Sa | Treatment of autoimmune diseases with deep brain stimulation |
EP3413970B1 (en) * | 2016-02-12 | 2021-06-30 | Axonics, Inc. | External pulse generator device for trial nerve stimulation |
EP3484577A4 (en) | 2016-07-18 | 2020-03-25 | Nalu Medical, Inc. | Methods and systems for treating pelvic disorders and pain conditions |
US10543374B2 (en) * | 2016-09-30 | 2020-01-28 | Boston Scientific Neuromodulation Corporation | Connector assemblies with bending limiters for electrical stimulation systems and methods of making and using same |
US10124178B2 (en) | 2016-11-23 | 2018-11-13 | Bluewind Medical Ltd. | Implant and delivery tool therefor |
EP3585475B1 (en) | 2017-02-24 | 2024-04-03 | Nalu Medical, Inc. | Apparatus with sequentially implanted stimulators |
US10758734B2 (en) * | 2017-02-28 | 2020-09-01 | Boston Scientific Neuromodulation Corporation | Implantable medical device with a silicone housing |
US20180272134A1 (en) | 2017-03-21 | 2018-09-27 | Boston Scientific Neuromodulation Corporation | Microstimulator Having Body-Mounted Electrodes and Remote Electrode Leads |
US20180272138A1 (en) | 2017-03-21 | 2018-09-27 | Boston Scientific Neuromodulation Corporation | Microstimulator with Rigid Support Structure |
EP3384958A1 (en) * | 2017-04-03 | 2018-10-10 | BIOTRONIK SE & Co. KG | Feedthrough for implant components |
US20180353764A1 (en) | 2017-06-13 | 2018-12-13 | Bluewind Medical Ltd. | Antenna configuration |
US10702692B2 (en) | 2018-03-02 | 2020-07-07 | Aleva Neurotherapeutics | Neurostimulation device |
US11331501B2 (en) | 2018-06-22 | 2022-05-17 | Greatbatch Ltd. | Implantable pulse generator with multiple suture ports |
CN109472914A (en) * | 2018-11-20 | 2019-03-15 | 河北家和康孕信息技术有限公司 | A kind of self-supporting medical terminal and method |
WO2020242900A1 (en) | 2019-05-24 | 2020-12-03 | Axonics Modulation Technologies, Inc. | Trainer device for a neurostimulator programmer and associated methods of use with a neurostimulation system |
CN110840457B (en) * | 2019-12-12 | 2020-11-13 | 北京航空航天大学 | Two-dimensional EIT electrode array structure optimization method based on fringe field detection |
CN113856047B (en) * | 2021-08-23 | 2023-05-26 | 西湖大学 | Hypoglossal nerve stimulation device |
CN113694373A (en) * | 2021-09-01 | 2021-11-26 | 苏州景昱医疗器械有限公司 | Nerve electrical stimulation equipment and connecting module and connecting device thereof |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011059565A1 (en) * | 2009-11-11 | 2011-05-19 | Boston Scientific Neuromodulation Corporation | Structure for an implantable medical device having telemetry and charging coils within a case |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4276882A (en) * | 1979-05-18 | 1981-07-07 | Medtronic, Inc. | Lead anchoring device |
JPH05144494A (en) * | 1991-11-18 | 1993-06-11 | Matsushita Refrig Co Ltd | Hermetically sealed terminal and hermetic motor-driven compressor |
AU3233100A (en) * | 1999-04-26 | 2000-11-10 | Advanced Neuromodulation Systems, Inc. | Lead connector |
US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
JP2002263201A (en) * | 2001-03-08 | 2002-09-17 | Terumo Corp | Implantable medical device |
US6721602B2 (en) * | 2001-08-21 | 2004-04-13 | Medtronic, Inc. | Implantable medical device assembly and manufacturing method |
JP4193975B2 (en) * | 2002-10-24 | 2008-12-10 | 株式会社生方製作所 | Airtight terminal unit |
US7719854B2 (en) * | 2003-07-31 | 2010-05-18 | Cardiac Pacemakers, Inc. | Integrated electromagnetic interference filters and feedthroughs |
US20050131483A1 (en) | 2003-12-11 | 2005-06-16 | Jennifer Zhao | Connector header setscrew for an implantable medical device |
US20050203584A1 (en) * | 2004-03-10 | 2005-09-15 | Medtronic, Inc. | Telemetry antenna for an implantable medical device |
US7083474B1 (en) * | 2004-12-08 | 2006-08-01 | Pacesetter, Inc. | System for lead retention and sealing of an implantable medical device |
US7337003B2 (en) * | 2005-01-25 | 2008-02-26 | Advanced Bionics Corporation | Implantable pulse generator case |
US7775215B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device positioning and obtaining pressure data |
US7244150B1 (en) | 2006-01-09 | 2007-07-17 | Advanced Bionics Corporation | Connector and methods of fabrication |
JP2008053007A (en) * | 2006-08-23 | 2008-03-06 | Sony Corp | Multicore current introduction terminal and cable |
US8224450B2 (en) * | 2006-09-18 | 2012-07-17 | Boston Scientific Neuromodulation Corporation | Feed through interconnect assembly for an implantable stimulation system and methods of making and using |
US8233986B2 (en) * | 2007-07-12 | 2012-07-31 | Medtronic, Inc. | Connector header for implantable medical device |
US8082037B2 (en) | 2007-07-12 | 2011-12-20 | Medtronic, Inc. | Form for retaining battery in implantable medical device |
US9162068B2 (en) | 2007-07-16 | 2015-10-20 | Boston Scientific Neuromodulation Corporation | Energy efficient resonant driving circuit for magnetically coupled telemetry |
JP2011517970A (en) * | 2008-03-20 | 2011-06-23 | グレイトバッチ リミテッド | Shielded 3-terminal flat-through EMI / energy dissipation filter |
US7736191B1 (en) * | 2008-05-27 | 2010-06-15 | Jerzy Roman Sochor | Implantable connector with protected contacts |
US7941227B2 (en) * | 2008-09-03 | 2011-05-10 | Boston Scientific Neuromodulation Corporation | Implantable electric stimulation system and methods of making and using |
WO2010035177A1 (en) | 2008-09-25 | 2010-04-01 | Koninklijke Philips Electronics N.V. | Apparatus with wireless communication module |
US9370664B2 (en) | 2009-01-15 | 2016-06-21 | Boston Scientific Neuromodulation Corporation | Signaling error conditions in an implantable medical device system using simple charging coil telemetry |
EP2611499A1 (en) | 2010-08-31 | 2013-07-10 | Boston Scientific Neuromodulation Corporation | Control module with a connector assembly retainer |
US8989872B2 (en) * | 2012-11-14 | 2015-03-24 | Medtronic, Inc. | Implantable medical device header |
-
2012
- 2012-02-23 JP JP2013555570A patent/JP2014508600A/en active Pending
- 2012-02-23 US US13/403,779 patent/US8738138B2/en not_active Expired - Fee Related
- 2012-02-23 AU AU2012220569A patent/AU2012220569B2/en active Active
- 2012-02-23 WO PCT/US2012/026370 patent/WO2012116214A1/en active Application Filing
- 2012-02-23 CA CA2828234A patent/CA2828234A1/en not_active Abandoned
- 2012-02-23 EP EP12707023.3A patent/EP2678072B1/en active Active
- 2012-02-23 EP EP22168815.3A patent/EP4062968A1/en not_active Withdrawn
- 2012-02-23 EP EP23157722.2A patent/EP4218917A1/en active Pending
-
2014
- 2014-04-11 US US14/251,488 patent/US8989864B2/en active Active
-
2015
- 2015-03-19 US US14/663,222 patent/US9597519B2/en active Active
-
2017
- 2017-02-24 US US15/442,324 patent/US9907966B2/en not_active Expired - Fee Related
-
2018
- 2018-01-17 US US15/873,705 patent/US10279188B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011059565A1 (en) * | 2009-11-11 | 2011-05-19 | Boston Scientific Neuromodulation Corporation | Structure for an implantable medical device having telemetry and charging coils within a case |
Non-Patent Citations (1)
Title |
---|
See also references of WO2012116214A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP4218917A1 (en) | 2023-08-02 |
EP4062968A1 (en) | 2022-09-28 |
US9597519B2 (en) | 2017-03-21 |
US9907966B2 (en) | 2018-03-06 |
US8989864B2 (en) | 2015-03-24 |
US20120221074A1 (en) | 2012-08-30 |
CA2828234A1 (en) | 2012-08-30 |
US8738138B2 (en) | 2014-05-27 |
US20140222111A1 (en) | 2014-08-07 |
EP2678072B1 (en) | 2022-06-15 |
JP2014508600A (en) | 2014-04-10 |
US10279188B2 (en) | 2019-05-07 |
US20180154160A1 (en) | 2018-06-07 |
US20170157406A1 (en) | 2017-06-08 |
US20150190645A1 (en) | 2015-07-09 |
WO2012116214A1 (en) | 2012-08-30 |
AU2012220569B2 (en) | 2016-04-28 |
AU2012220569A1 (en) | 2013-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10279188B2 (en) | Implantable medical device for providing stimulation therapy | |
EP2121126B1 (en) | Filtering capacitor feedthrough assembly | |
EP2497527B1 (en) | Low insertion force electrical connector for implantable medical devices | |
US10420950B2 (en) | Implantable pulse generator usable during a trial stimulation phase and externally powered by magnetic inductive coupling | |
US20180272134A1 (en) | Microstimulator Having Body-Mounted Electrodes and Remote Electrode Leads | |
US20180272138A1 (en) | Microstimulator with Rigid Support Structure | |
US10016593B2 (en) | Implantable medical device having electromagnetic interference filter device to reduce pocket tissue heating | |
EP3946569B1 (en) | Low-profile control module for an electrical stimulation system | |
US20240238602A1 (en) | Implantable medical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130920 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190503 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220110 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602012078359 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1497992 Country of ref document: AT Kind code of ref document: T Effective date: 20220715 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220915 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220916 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220915 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1497992 Country of ref document: AT Kind code of ref document: T Effective date: 20220615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221017 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221015 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602012078359 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
26N | No opposition filed |
Effective date: 20230316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20230228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230223 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230228 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230228 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240123 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20240125 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240123 Year of fee payment: 13 Ref country code: GB Payment date: 20240123 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240123 Year of fee payment: 13 |